GL1X · GenesisL1 explorer

Research workbench

The crystal structure of HTLV protease complexed with the inhibitor kni-10681

Analyse The crystal structure of HTLV protease complexed with the inhibitor kni-10681 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3LIT
Type
protein
Length
232 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protease
UniProt
Q82134
Ligands
E15
Pockets
1 · best druggability 0.69

Structure

x-ray diffraction · 1 distinct chain · 8% helix, 41% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BProteaseprotein1168% helix, 41% strandQ82134

Ligands and binding sites

  • E15 · (4R)-3-[(2S,3S)-3-[[(2S)-2-[[(2S)-2-azanyl-2-phenyl-ethanoyl]amino]-3,3-dimethyl-butanoyl]amino]-2-hydroxy-4-phenyl-but anoyl]-5,5-dimethyl-N-[(2R)-3-methylbutan-2-yl]-1,3-thiazolidine-4-carboxamide · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15070.690.7942E15

Interfaces

1 interface between chains.

  • A–B · 2011 Ų buried · 30 hydrogen bonds · protein-protein

Compared structures

  • 3LIT · The crystal structure of htlv protease complexed with the inhibitor KNI-10681 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.